Codes / ICD10CM / M10.49

M10.49 Other secondary gout, multiple sites

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Other secondary gout, multiple sites

Summary

Other secondary gout, multiple sites is a form of arthritis characterized by the deposition of urate crystals in multiple joints, typically resulting from elevated uric acid levels due to identifiable underlying conditions or factors. It differs from primary gout in that the hyperuricemia is secondary to another disorder or medication use, leading to widespread joint inflammation.

Causes

Other secondary gout, multiple sites occurs when uric acid levels rise due to conditions or treatments that affect uric acid metabolism or excretion. Common causes include kidney disease, certain medications (e.g., diuretics), hematologic disorders, or other systemic illnesses that disrupt uric acid balance, promoting crystal formation in multiple joints.

Risk Factors

  • Chronic kidney disease
  • Use of medications affecting uric acid levels (e.g., diuretics)
  • Myeloproliferative disorders
  • Chemotherapy or radiation therapy
  • Obesity
  • Diets high in purine-rich foods or fructose-sweetened beverages

Symptoms

  • Sudden, intense joint pain and swelling in multiple sites
  • Redness, warmth, and tenderness in affected joints
  • Limited range of motion
  • Flare-ups that may occur without warning

Diagnosis

Diagnosis involves a physical examination of affected joints, blood tests to measure uric acid levels, and joint fluid analysis to detect urate crystals. Imaging studies (e.g., X-ray, ultrasound) may be used to assess joint damage or rule out other conditions.

Treatment Options

  • Nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce pain and inflammation
  • Colchicine to manage acute flare-ups
  • Corticosteroids for severe inflammation
  • Urate-lowering therapy (e.g., allopurinol) to address underlying hyperuricemia
  • Lifestyle modifications to reduce risk factors

Prognosis and Follow-Up

Prognosis depends on the underlying cause and timely management of uric acid levels. Regular follow-up is essential to monitor joint function, adjust treatments, and prevent complications. Long-term control of hyperuricemia can reduce flare-ups and joint damage.

Complications

  • Chronic joint damage or deformity
  • Tophi (urate crystal deposits) in multiple sites
  • Kidney stones or renal impairment
  • Increased risk of cardiovascular disease

Lifestyle & Prevention

  • Maintain a balanced diet low in purine-rich foods (e.g., red meat, seafood)
  • Limit alcohol and fructose-sweetened beverages
  • Stay hydrated to support uric acid excretion
  • Manage weight through regular exercise
  • Avoid medications that elevate uric acid levels when possible

When to Seek Professional Help

Seek medical attention if you experience sudden, severe joint pain, swelling, or redness in multiple sites, especially if symptoms persist or worsen. Prompt evaluation is important to rule out infection or other serious conditions.

Tips for Medical Coders

Document the specific sites affected by gout to support the "multiple sites" designation. Ensure underlying causes (e.g., kidney disease, medication use) are clearly recorded, as these differentiate secondary gout from primary forms. Verify that the code M10.49 is used only when multiple sites are involved and not for single-site or unspecified cases.

Book a walkthrough

M10.49 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.